AST SpaceMobile (ASTS) delivered earnings and revenue surprises of -17.65% and 82.05%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

US telco giant AT&T has updated its customers on the impact that satellite operator AST SpaceMobile (AST) will make when its ...

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

AST SpaceMobile, Inc. (ASTS) reachead $25.08 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.

The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma peer GSK. The post Does the GSK or AstraZeneca share price currently offer the ...

Pinterest (PINS) surprised investors with stronger-than-expected first-quarter revenue and an upbeat current-quarter forecast ...

Summing up, AstraZeneca’s positioned as a growth-focused company with a higher share price relative to earnings, lower dividend yield, faster revenue growth, and a strong commitment to reducing ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

As of early March 2025 for Q4 2024 earnings, AST beat the Zacks Consensus earnings per share (EPS) by 2 cents, at negative 18 cents and quarterly net loss of $35.9 million, which is up from the net ...

(Alliance News) - AstraZeneca PLC on Monday announced that its medicine Trixeo Aerosphere has been approved by the UK Medicines & Healthcare Products Regulatory Agency with "an innovative, ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.